Liposome can encapsulate both polar and nonpolar materials, so then many applied studies are conducted as a drug delivery system (DDS) for various drugs. In particular, it is a next-generation drug delivery vectors in the field of gene therapy, targeted anticancer drugs, immuno-cancer drugs, and synthetic drugs. Using the original technology of Ectosome Inc., we can produce liposomes with excellent stability and can design sustaining the characteristics of drugs guideline by KFDA and FDA.

Carbon nanotube (CNT) is applied in various biomedical fields, including imaging and cancer treatment, due to its mechanical, visual, and chemical properties. Especially, CNT is being studied as a drug delivery vector for various biomolecules, including anticancer drugs, plasmid DNA, and siRNA, into the cell through endocytosis. Ectosome Inc. can produce CNT-based anticancer drugs that inhibit multidrug resistance (MDR) of cancer cells using original technology.